SIX directors at mining company Shanta Gold went into the market to buy shares last week in the wake of results.
Non-executive director Jonathan Leslie was the biggest buyer, purchasing 560,000 shares at a price of 17.75p each, taking his stake to 13.14 million.
The company said it has had a “positive start to the year both from a corporate and operational perspective”.
• Giles Clarke, chairman of South Africa-focused metals business Ironveld, has seen his family’s interest in shares increase with the purchase of a million shares at 4.5p each.
He now holds 15.3 million shares in the company.
• James Barder, chief executive of healthcare company Futura Medical, has seen his non-beneficial interest increased to 352,500 ordinary shares after a family trust bought 43,500 shares at 65 pence per share each.
• Two directors at resources group Neos have upped their stakes in the company.
Nicholas Myerson, through his personal holding and operating company Beneficium Sarl, has purchased 210,000 shares at 0.695p each.
Ravi Jose has purchased 1.1 million shares at a similar price.
• Andrew Sarosi, an executive director at mining and metals group Jubilee, has bought 64,444 shares at 7.72p each.
It was his first purchase of shares in the company.
• Chris Brewster, the newly appointed chief financial officer of veterinary pharmaceuticals firm Animalcare, has purchased 4,079 shares at 122.5p each.
This represented his first purchase of shares in the company. Brewster was previously group accounting manager at Findus.
• Trevor Dighton, who recently announced plans to retire from security business G4S, has sold 400,000 shares at 295.80p each.
• Anthony Balme, executive chairman of exploration and development company Ortac Resources, has acquired two million shares at 0.27p per share.
Balme now has an interest in 165 million shares, representing 7.1 per cent of the company.
• George Blunden, a non-executive director at insurer Beazley, has sold 57,156 shares at 215.02p each.